Addgene: pcDNA3-HER2-DMVF-181-N
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - Annals of Oncology
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs
Clinical applications of mouse models for breast cancer engaging HER2/neu
HER2/neu - Wikipedia
Real-time detection of cancer marker, HER2, using a... | Download Scientific Diagram
BMS-599626 (AC480), HER1 and HER2 inhibitor (ab142063) | アブカム
PLOS ONE: HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram
-Western-Blot-NBP2-34472-img0007.jpg "ErbB2/Her2 Antibody (CL0269) (NBP2-34472): Novus Biologicals")
ErbB2/Her2 Antibody (CL0269) (NBP2-34472): Novus Biologicals
Increased expression of proliferation markers and her2/neu in neuT-C3... | Download Scientific Diagram
Identification of gene markers for HER2+, Luminal A/B and TNBC. (A)... | Download Scientific Diagram
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR | Oncogene
Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library
Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer | PNAS
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
